SCHEMBL6257356

SCHEMBL6257356

O=C(N[C@H](C(=O)N1CCCCC1)c1ccccc1)c1ccc(CNC(=O)c2ccccc2-c2ccc(C(F)(F)F)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MTTP P55157 18/20 1.00
KLRK1 P26718 2/20 0.67
MICA Q29983 2/20 0.67
RAET1L Q5VY80 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6257358 1.00 MTTP (1.00) MTTPKLRK1MICARAET1L
SCHEMBL6254466 0.91 MTTP (1.00) MTTPKLRK1MICARAET1L
SCHEMBL6254470 0.91 MTTP (1.00) MTTPKLRK1MICARAET1L
SCHEMBL6805734 0.85 MTTP (1.00) MTTP
SCHEMBL6805732 0.85 MTTP (1.00) MTTP
SCHEMBL6256963 0.80 MTTP (0.72) MTTP
SCHEMBL6266170 0.75 MTTP (0.66) MTTP
SCHEMBL15556509 0.75 MTTP (0.66) MTTP
SCHEMBL7608025 0.74 MTTP (0.60) MTTPKLRK1MICARAET1L
SCHEMBL14027951 0.73 MTTP (0.57) MTTPKLRK1MICARAET1L

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040132745-A1 Microsomal triglyceride transfer protein inhibitor PFIZER INC 2004-07-08 US claimed
EP-1578725-A1 MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITORS Pfizer Products Inc. (US) 2005-09-28 EP disclosed
WO-2004056777-A1 MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITORS PFIZER PRODUCTS INC. (US) 2004-07-08 WO disclosed
US-20040132745-A1 Microsomal triglyceride transfer protein inhibitor PFIZER INC 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132745-A1 Microsomal triglyceride transfer protein inhibitor MTTP, CETP, APOB MTTP 1/4885KLRK1 3508/4885MICA 932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.